Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P40
Within normal range
vs 2Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -29.56% |
| Q3 2025 | -33.14% |
| Q2 2025 | 19.31% |
| Q1 2025 | -42.48% |
| Q4 2024 | 39.56% |
| Q3 2024 | 34.18% |
| Q2 2024 | 21.48% |
| Q1 2024 | -78.38% |
| Q4 2023 | 45.73% |
| Q3 2023 | -5866.18% |
| Q2 2023 | 95.44% |
| Q1 2023 | -187.63% |
| Q4 2022 | -210.44% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |